**8. References**


Genetics of Amyotrophic Lateral Sclerosis 501

Chen W., et al. (2006). Lack of association of VEGF promoter polymorphisms with sporadic ALS. *Neurology*, Vol. 67, No. 3, (August 2006), pp. 508-510, ISSN 0028-3878 Chen Y., et al. (2011). Ataxin-2 intermediate-length polyglutamine: a possible risk factor for

Chen YZ., et al. (2004). DNA/RNA helicase gene mutations in a form of juvenile

Chió A., et al. (1991). Risk factors in motor neuron disease: a case-control study. *Neuroepidemiology*, Vol. 10, No. 4, (1991), pp 174-184, ISSN 0251-5350 Chiò A., et al. (2009). A two-stage genome-wide association study of sporadic amyotrophic

Choi M., et al. (2009). Genetic diagnosis by whole exome capture and massively parallel

Chow CY., et al. (2007). Mutation of FIG4 causes neurodegeneration in the pale tremor

Chow CY., et al. (2009). Deleterious variants of FIG4, a phosphoinositide phosphatase, in

Conforti FL., et al. (2007). A novel angiogenin gene mutation in a sporadic patient with

Coppedè F., et al. (2008). Lack of association between the APEX1 Asp184Glu polymorphism

Corbo M & Hays AP. (1992). Peripherin and neurofilament protein coexist in spinal

Corcia P., et al. (2006). SMN1 gene, but not SMN2, is a risk factor for sporadic ALS. *Neurology*, Vol. 67, No. 7, (October 2006), pp. 1147-1150, ISSN 0028-3878 Corcia P., et al. (2009). The importance of the SMN genes in the genetics of sporadic ALS.

Corrado L., et al. (2007). Variations in the coding and regulatory sequences of the

Corrado L., et al. (2009). High frequency of TARDBP gene mutations in Italian patients with

*Neurology*, Vol. 51, No. 5, (September 1992), pp. 531-537, ISSN 0022-3069 Corcia P., et al. (2002). Abnormal SMN1 gene copy number is a susceptibility factor for

No. 45, (November 2009), pp. 19096-19101, ISSN 0027-8424

Ahead of print, ISSN 0197-4580

1532, ISSN 0964-6906

ISSN 0028-0836

2009), pp. 85-88, ISSN 0002-9297

pp. 243-246, ISSN 0364-5134

pp. 123-127, ISSN 0022-510X

694, ISSN 1059-7794

ISSN 1748-2968

No. 1, (January 2008), pp. 68-70, ISSN 0960-8966

(February 2010), pp. 353-355, ISSN 0197-4580

No. 6, (June 2004), pp. 1128-1135, ISSN 0002-9297

Chinese patients with amyotrophic lateral sclerosis. *Neurobiology of Aging*, 2011,

amyotrophic lateral sclerosis (ALS4). *American Journal of Human Genetics*, Vol. 74,

lateral sclerosis. *Human Molecular Genetics*, Vol. 18, No. 8, (April 2009), pp. 1524-

DNA sequencing. *Proceedings of the National Academy of Sciences of the USA*, Vol. 106,

mouse and patients with CMT4J. *Nature*, Vol. 448, No. 7149, (July 2007), pp. 68-73,

patients with ALS. *American Journal of Human Genetics*, Vol. 84, No. 1, (January

amyotrophic lateral sclerosis from southern Italy. *Neuromuscular Disorders*, Vol. 18,

and sporadic amyotrophic lateral sclerosis. *Neurobiology of Aging*, Vol. 31, No. 2,

spheroids of motor neuron disease. *Journal of Neuropathology and Experimental* 

amyotrophic lateral sclerosis. *Annals of Neurology*, Vol. 51, No. 2, (February 2002),

*Amyotrophic Lateral Sclerosis*, Vol. 10, No. 5-6, (October-December 2009), pp. 436-440,

angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population. *Journal of Neurological Sciences*, Vol. 258, No. 1-2, (July 2007),

amyotrophic lateral sclerosis. *Human Mutation*, Vol. 30, No. 4, (April 2009), pp. 688-


Benajiba L., et al. (2009). TARDBP mutations in motoneuron disease with frontotemporal

Blauw HM., et al. (2010). A large genome scan for rare CNVs in amyotrophic lateral

Bosco DA., et al. (2010). Mutant FUS proteins that cause amyotrophic lateral sclerosis

Bose JK., et al. (2008). TDP-43 overexpression enhances exon 7 inclusion during the survival

Boxer AL., et al. (2010). Clinical, neuroimaging and neuropathological features of a new

Brockington A., et al. (2006). Expression of vascular endothelial growth factor and its

Broeke JHP., et al. (2010). Munc18 and Munc13 regulate early neurite outgrowth. *Biology of* 

Buratti E & Baralle FE. (2010). The multiple roles of TDP-43 in pre-mRNA processing and

Byrne S., et al. (2010). Rate of familial amyotrophic lateral sclerosis: a systematic review and

Cai H., et al. (2008). ALS2/alsin knockout mice and motor neuron diseases. *Neurodegenerative diseases*, Vol. 5, No. 6, (2008), pp. 359-366, ISSN 1660-2854 Calvo A., et al. (2010). Involvement of immune response in the pathogenesis of amyotrophic

Chance PF., et al. (1998). Linkage of the gene for an autosomal dominant form of juvenile

Chen D., et al. (2007). Association of polymorphisms in vascular endothelial growth factor

Chen HJ., et al. (2010). Characterization of the properties of a novel mutation in VAPB in

*the Cell*, Vol. 102, No. 8, (June 2010), pp. 479-488, ISSN 0248-4900

*Targets*, Vol. 9, No. 3, (July 2010), pp. 325-330, ISSN 1871-5273

*Genetics*, Vol. 62, No. 3, (March 1998), pp. 633-640, ISSN 0002-9297

*Sclerosis*, Vol. 8, No. 3, (June 2007), pp. 144-149, ISSN 1748-2968

51, (December 2010), pp. 40266-40281, ISSN 0021-9258

*Psychiatry*, Vol.82, No.2, (February 2011), pp.196-203, ISSN 0022-3050 Brockington A., et al. (2005). Screening of the regulatoy and coding regions of vascular

ISSN 0364-5134

ISSN 0964-6906

ISSN 0022-3069

429, ISSN 1547-6286

Blauw HM., et al. *Neurology*, 2011;in press

(November 2010), pp. 4160-4175, ISSN 0964-6906

43, (October 2008), pp. 28852-28859, ISSN 0021-9258

2, (May 2005), pp. 101-104, ISSN 1364-6745

(June 2011), pp. 623-627, ISSN 0022-3050

lobar degeneration. *Annals of Neurology*, Vol. 65, No. 4, (April 2009), pp. 470-473,

sclerosis. *Human Molecular Genetics*, Vol. 19, No. 20, (October 2010), pp. 4091-4099,

incorporate into stress granules. *Human Molecular Genetics*, Vol. 19, No. 21,

of motor neuron pre-mRNA splicing. *Journal of Biological Chemistry*, Vol. 283, No.

chromosome 9p-linked FTD-ALS family*. Journal of Neurology, Neurosurgery and* 

endothelial growth factor in amyotrophic lateral sclerosis. *Neurogenetics*, Vol. 6, No.

receptors in the central nervous system in amyotrophic lateral sclerosis. *Journal of Neuropathology and Experimental Neurology*, Vol. 65, No. 1, (January 2006), pp. 26-36,

gene expression regulation. *RNA Biology*, Vol. 7, No. 4, (July-August 2010), pp. 420-

meta-analysis. *Journal of Neurology, Neurosurgery, and Psychiatry*, Vol. 82, No. 6,

lateral sclerosis: a therapeutic opportunity? *CNS & Neurological Disorders Drug* 

amyotrophic lateral sclerosis to chromosome 9q34. *American Journal of Human* 

gene with the age of onset of amyotrophic lateral sclerosis. *Amyotrophic Lateral* 

familial amyotrophic lateral sclerosis. *Journal of Biological Chemistry*, Vol. 285, No.


Genetics of Amyotrophic Lateral Sclerosis 503

Del Bo R., et al. (2011). Novel optineurin mutations in patients with familial and sporadic

Delisle MB & Carpenter S. (1984). Neurofibrillary axonal swellings and amyotrophic lateral

Deng HX., et al. (2010). FUS-immunoreactive inclusions are a common feature in sporadic

Deng HX., et al. (2011). Mutations in UBQLN2 cause dominant X-linked juvenile and adult-

De Weerd NA, Samarajiwa SA & Hertzog PJ. (2007). Type I interferon receptors:

Dickson SP., et al. (2010). Rare variants create synthetic genome-wide associations. *PLoS* 

Dion PA, Daoud H & Rouleau GA. (2009). Genetics of motor neuron disorders: new insights

Dormann D., et al. (2010). ALS-associated fused in sarcoma (FUS) mutations disrupt

Draganov DI., et al. (2000). Rabbit serum paraoxonase 3 (PON3) is a high density

Dunckley T., et al. (2007). Whole-genome analysis of sporadic amyotrophic lateral sclerosis.

Echaniz-Laguna A., et al. (2002). Homozygous exon 7 deletion of the SMN centromeric gene

Eggert C., et al. (2006). Spinal muscular atrophy: the RNP connection. *Trends in Molecular* 

Elamin M., et al. (2011). Executive dysfunction is a negative prognostic indicator in patients

Elden AC., et al. (2010). Ataxin-2 intermediate-length polyglutamine expansions are

Ewing RM., et al. (2007). Large-scale mapping of human protein-protein interactions by

Farrer MJ., et al. (2009). DCTN1 mutations in Perry syndrome. *Nature Genetics*, Vol. 41, No.

*Medicine*, Vol. 12, No. 3, (March 2006), pp. 113-121, ISSN 1471-4914

*Biology*, Vol. 8, No. 1, (January 2010), e1000294, ISSN 1544-9173

2001, Ahead of print, ISSN 0022-3050

No. 6, (June 2010), pp. 739-748, ISSN 0364-5134

28, (July 2007), pp. 20053-20057, ISSN 0021-9258

2009), pp. 769-782, ISSN 1471-0056

2010), pp. 2841-2857, ISSN 0261-4189

33442, ISSN 0021-9258

0028-4793

ISSN 0028-3878

pp.1069-1075, ISSN 0028-0836

2, (February 2009), pp. 163-165, ISSN 1061-4036

5354

250, ISSN 0022-510X

215, ISSN 0028-0836

amyotrophic lateral sclerosis. *Journal of Neurology, Neurosurgery, and Psychiatry*,

sclerosis. *Journal of the Neurological Sciences*, Vol. 63, No. 2, (February 1984), pp. 241-

and non-SOD1 familial amyotrophic lateral sclerosis. *Annals of Neurology*, Vol. 67,

onset ALS and ALS/dementia. *Nature*, Vol. 477, No. 7363, (August 2011), pp. 211-

biochemistry and biological functions. *Journal of Biological Chemistry*, Vol. 282, No.

into pathogenic mechanisms. *Nature Reviews. Genetics*, Vol. 10, No. 11, (November

Transportin-mediated nuclear import. *EMBO Journal*, Vol. 29, No. 16, (August

lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. *Journal of Biological Chemistry*, Vol. 275, No. 43, (October 2000), pp. 33435-

*New England Journal of Medicine*, Vol. 357, No. 8, (August 2007), pp. 775-788, ISSN

(SMN2): a potential susceptibility factor for adult-onset lower motor neuron disease. *Journal of Neurology*, Vol. 249, No. 3, (March 2002), pp. 290-293, ISSN 0340-

with ALS without dementia. *Neurology*, Vol. 76, No. 14, (April 2011), pp. 1263-1269,

associated with increased risk for ALS. *Nature*, Vol. 466, No.7310, (August 2010),

mass spectrometry. *Molecular Systems Biology*, Vol. 3, (2007), pp. 89, ISSN 1744-4292


Corrado L., et al. (2009). Mutations of FUS gene in sporadic amyotrophic lateral sclerosis.

Corrado L., et al. (2010). A novel peripherin gene (PRPH) mutation identified in one

Costa LG., et al. (2005). Modulation of paraoxonase (PON1) activity. *Biochemical Pharmacology*, Vol. 69, No. 4, (February 2005), pp. 541-550, ISSN 0006-2952 Couillard-Després S., et al. (1998). Protective effect of neurofilament heavy gene

Cox LE., et al. (2010). Mutations in CHMP2B in lower motor neuron predominant

Cronin S., et al. (2007). Paraoxonase promoter and intronic variants modify risk of sporadic

Cronin S,. et al. (2007). A genome-wide association study of sporadic ALS in a homogenous

Cronin S., et al. (2008). Screening for replication of genome-wide SNP associations in

Crow MK. (2010). Type I interferon in organ-targeted autoimmune and inflammatory diseases. *Artrhitis Research and Therapy*, Vol.12, (2010), Suppl.1:S5, ISSN 1478-6354 Da Cruz S & Cleveland DW. (2011). Understanding the role of TDP-43 and FUS/TLS in ALS

Daoud H., et al. (2010). Analysis of DPP6 and FGGY as candidate genes for amyotrophic

Daoud H., et al. (2011). Association of long ATXN2 CAG repeat sizes with increased risk of

Dedoni S, Olianas MC & Onali P. (2010). Interferon-β induces apoptosis in human SH-Sy5Y

Dejesus-Hernandez M et al. (2011). Expanded GGGGCC hexanucleotide repeat in

Del Bo R., et al. (2006). Absence of angiogenic genes modification in Italian ALS patients. *Neurobiology of Aging*, Vol. 29, No. 2, (February 2008), pp. 314-316, ISSN 0197-4580 Del Bo R., et al. (2008). DPP6 gene variability confers increate risk of developing sporadic

*and Psychiatry*, Vol. 79, No. 9, (September 2008), pp. 1085, ISSN 0022-3050

and beyond. *Current Opinion in Neurobiology*, 2011:Ahead of print

78, No. 9, (September 2007), pp. 984-986, ISSN 0022-3050

(March 2011), pp. 552.e1-6, ISSN 0197-4580

1998), pp. 9626-9630, ISSN 0027-8424

ISSN 1932-6203

774, ISSN 0964-6906

391, ISSN 1748-2968

739-742, ISSN 0003-9942

pp. 1421-1433, ISSN 0022-3042

*Neuron*, September 2011, Ahead of print.

pp. 213-218, ISSN 1018-4813

*Journal of Medical Genetics*, Vol. 47, No. 3, (March 2010), pp. 190-194, ISSN 0022-2593

sporadic amyotrophic lateral sclerosis patients. *Neurobiology of Aging*, Vol. 32, No. 3,

overexpression in motor neuron disease induced by mutant superoxide dismutase. *Proceedings of the National Academy of Sciences of the USA*, Vol. 95, No. 16, (August

amyotrophic lateral sclerosis (ALS). *PLoS One*, Vol. 5, No. 3, (March 2010), e9872,

amytrophic lateral sclerosis. *Journal of Neurology, Neurosurgery, and Psychiatry*, Vol.

Irish population. *Human Molecular Genetics*, Vol. 17, No. 5, (March 2008), pp. 768-

sporadic ALS. *European Journal of Human Genetics*, Vol. 17, No. 2, (February 2009),

lateral sclerosis. *Amyotrophic Lateral Sclerosis*, Vol. 11, No. 4, (August 2011), pp. 389-

amyotrophic lateral sclerosis. *Archives of Neurology*, Vol. 68, No. 6, (June 2011), pp.

neuroblasto cells through activation of JAK-STAT signaling and down-regulation of PI3K/Akt pathway. *Journal of Neurochemistry*, Vol. 115, No. 6, (December 2010),

noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

amyotrophic lateral sclerosis in Italian patients. *Journal of Neurology, Neurosurgery,* 


Genetics of Amyotrophic Lateral Sclerosis 505

Golenia A., et al. (2010). Lack of association between VEGF gene polymorphisms and

Greenway MJ., et al. (2004). A novel candidate region for ALS on chromosome 14q11.2. *Neurology*, Vol. 63, No. 10, (November 2004), pp. 1936-1938, ISSN 0028-3878 Greenway MJ., et al. (2006). ANG mutations segregate with familial and 'sporadic'

Groen EJ., et al. (2010). FUS mutations in amyotrophic lateral sclerosis in the Netherlands. *Archives of Neurology*, Vol. 67, No. 2, (February 2010), pp. 224-230, ISSN 0003-9942 Grohmann K., et al. (2011). Mutations in the gene encoding immunoglobulin mu-binding

Hadano S., et al. (2001. A gene encoding a putative GTPase regulator is mutated in familial

Hadano S., et al. (2005). Mice deficient in the Rab5 guanine nucleotide exchange factor

Hand CK., et al. (2001). A novel locus for familial amyotrophic lateral sclerosis on

Haraguchi K., et al. (2005). Role of the kinesin-2 family protein, KIF3, during mitosis. *Journal* 

Harley IT., et al. (2010). The role of genetic variation near interferon-kappa in systemic lupus erythematosus. *Journal of Biomedicine and Biotechnology*, 2010, ISSN 1110-7243 Hayward C., et al. (1999). Molecular genetic analysis of the APEX nuclease gene in

He X., et al. (2011). H63D polymorphism in the hemochromatosis gene is associated with

He CZ & Hays AP. (2004). Expression of peripherin in ubiquitinated inclusions of

Hentati A., et al. (1994). Linkage of recessive familial amyotrophic lateral sclerosis to

Hentati A., et al. (1998). Linkage of a commoner form of recessive amyotrophic lateral

18, No. 2, (February 2011), pp. 359-361, ISSN 1351-5101

(January 2004), pp. 47-54, ISSN 0022-510X

1998), pp. 55-60, ISSN 1364-6745

*Genetics*, Vol. 29, No. 1, (September 2001), pp. 75-77, ISSN 1061-4036 Gurney ME., et al. (1994). Motor neuron degeneration in mice that express a human Cu,Zn

2010), pp. 2035-2037, ISSN 0028-3878

413, ISSN 1061-4036

1775, ISSN 0036-8075

ISSN 0964-6906

ISSN 0028-3878

1061-4036

9258

pp.166-173, ISSN 1061-4036

2002), pp.251-256, ISSN 0002-9297

plasma VEGF levels and sporadic ALS. *Neurology*, Vol. 75, No. 22, (November

amyotrophic lateral sclerosis. *Nature Genetics*, Vol. 38, No. 4, (April 2006), pp. 411-

protein 2 cause spinal muscular atrophy with respiratory distress type 1. *Nature* 

superoxide dismutase mutation. *Science*, Vol. 264, No. 5166, (June 1994), pp. 1772-

amyotrophic lateral sclerosis 2. *Nature Genetics*, Vol.29, No.2, (October 2001),

ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. *Human Molecular Genetics*, Vol. 15, No. 2, (January 2006), pp. 233-250,

chromosome 18q. *The American Journal of Human Genetics*, Vol. 70, No.1, (January

*of Biological Chemistry*, Vol. 281, No. 7, (February 2006), pp. 4094-4099, ISSN 0021-

amyotrophic lateral sclerosis. *Neurology*, Vol. 52, No. 9, (June 1999), pp. 1899-1901,

sporadic amyotrophic lateral sclerosis in China. *European Journal of Neurology*, Vol.

amyotrophic lateral sclerosis. *Journal of Neurological Sciences*, Vol. 217, No. 1,

chromosome 2q33-q35. *Nature Genetics*, Vol. 7, No. 3, (July 1994), pp. 425-428, ISSN

sclerosis to chromosome 15q15-q22 markers. *Neurogenetics*, Vol. 2, No. 1, (December


Feder JN., et al. (1998). The hemochromatosis gene product complexes with the transferrin

Fernández-Santiago R., et al. (2006). Possible gender-dependent association of vascular

Fernández-Santiago R., et al. (2009). Identification of novel Angiogenin (ANG) gene

Figlewicz DA., et al. (1994). Variants of the heavy neurofilament subunit are associated with

Fishel ML & Kelley MR. (2007). The DNA base excision repair protein Ape1/Ref-1 as a

Fogh I., et al. (2009) No association of DPP6 with amyotrophic lateral sclerosis in an Italian

Gamez J., et al. (2002). Survival and respiratory decline are not related to homozygous

Gavrilov DK., et al. (1998). Differential SMN2 expression associated with SMA severity. *Nature Genetics*, Vol. 20, No. 3, (November 1998), pp. 230-231, ISSN 1061-4036 Gellera C., et al. (2007). Identification of new ANG gene mutations in a large color of Italian

Gijselinck I., et al. (2010). Identification of 2 loci at chromosome 9 and 14 in a multiplex

Gitcho MA., et al. (2009). VCP mutations causing frontotemporal lobar degeneration disrupt

Gitcho MA., et al. (2009). TARDBP 3´UTR variant in autopsy-confirmed frontotemporal

Goodall EF., et al. (2005). Association of the H63D polymorphism in the hemochromatosis

No. 10, (October 1994), pp. 1757-1761, ISSN 0964-6906

3-4, (June-August 2007), pp. 375-395, ISSN 0098-2997

No. 18, (May 2009), pp. 12384-12398, ISSN 0021-9258

5, (November 2009), pp. 633-645, ISSN 0001-6322

*Neurology*, Vol. 256, No. 8, (August 2009), pp. 1337-1342, ISSN 1351-5101 Fernández-Santiago R., et al. (2009). No evidence of association of FLJ10986 and ITPR2 with

pp.1472-1477, ISSN 0027-8424

pp. 551.e1-4, ISSN 0197-4580

1456-1460, ISSN 0028-3878

2008), pp. 33-40, ISSN 1364-6745

of print, ISSN 0041-008X

ISSN 0028-3878

0197-4580

2006), pp. 1929-1931, ISSN 0028-3878

receptor and lowers its affinity for ligand binding. *Proceedings of the National Academy of Sciences of the United States of America*, Vol. 95, No. 4, (February 1998),

endothelial growth factor (VEGF) gene and ALS. *Neurology*, Vol. 66, No. 12, (June

missense variants in German patients with amyotrophic lateral sclerosis. *Journal of* 

ALS in a large German cohort. *Neurobiology of Aging*, Vol. 32, No. 3, (March 2011),

the development of amyotrophic lateral sclerosis. *Human Molecular Genetics*, Vol. 3,

therapeutic and chemopreventive target. *Molecular Aspects of Medicine*, Vol. 28, No.

population. *Neurobiology of Aging*, Vol. 32, No. 5, (May 2011), pp. 966-967, ISSN

SMN2 deletions in ALS patients. *Neurology*, Vol. 59, No. 9, (November 2002), pp.

patients with amyotrophic lateral sclerosis. *Neurogenetics*, Vol. 9, No. 1, (February

family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. *Archives of Neurology*, Vol. 67, No. 5, (May 2010), pp. 606-616, ISSN 0003-9942 Giordano G., et al. (2011). Paraoxonase 2 (PON2) in the mouse central nervous system: A

neuroprotective role? *Toxicology and Applied Pharmacology*, (February 2011), Ahead

localization of TDP-43 and induce cell death. *Journal of Biological Chemistry*, Vol. 284,

lobar degeneration with TDP-43 proteinopathy. *Acta Neuropathologica*, Vol. 118, No.

gene with sporadic ALS. *Neurology*, Vol. 65, No. 6, (September 2005), pp. 934-937,


Genetics of Amyotrophic Lateral Sclerosis 507

Ju JS & Weihl CC. (2010). Inclusion body myopathy, Paget's disease of the bone and

Ju S., et al. (2011). A yeast model of FUS/TLS-dependent cytotoxicity. *PLoS Biology*, Vol. 9,

Kabashi E., et al. (2008). TARDBP mutations in individuals with sporadic and familial

Kanekura K., et al. (2004). Alsin, the product of ALS2 gene, suppresses SOD1 mutant

Kiernan MC., et al. (2011). Amyotrophic lateral sclerosis. *Lancet*, Vol. 377, No. 9769, (March

Kisby GE, Milne J & Sweatt C. (1997). Evidence of reduced DNA repair in amyotrophic

Kohler RS., et al. (2010). Differential NDR/LATS interactions with the human MOB family

Kwiatkowski TJ Jr., et al. (2009). Mutations in the FUS/TLS gene on chromosome 16 cause

Laaksovirta H., et al. (2010). Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a

LaFleur DW., et al. (2001). Interferon-κ, a novel type I interferon expressed in human

Lagier-Tourenne C, Polymenidou M & Cleveland DW. (2010). TDP-43 and FUS/TLS:

Lambrechts D., et al. (2003). VEGF is a modifier of amyotrophic lateral sclerosis in mice and

Lambrechts D., et al. (2009). Meta-analysis of vascular endothelial growth factor variations

Landers JE., et al. (2008). A common haplotype within the PON1 promoter region is

Lariviere RC & Julien JP. (2004). Functions of intermediate filaments in neuronal

*Genetics*, Vol. 19, No. R1, (April 2010), pp. R46-R64, ISSN 0964-6906

No. 4, (August 2003), pp. 383-394, ISSN 1061-4036

19, No. R1, (April 2010), pp. R38-45, ISSN 0964-6906

No. 4, (April 2011), pp. e1001052, ISSN 1545-7885

574, ISSN 1061-4036

ISSN 0959-4965

1098-5549

2011), pp. 942-955, ISSN 0140-6736

pp. 1205-1208, ISSN 1095-9203

978-985, ISSN 1474-4422

840-846, ISSN 0022-2593

131-148, ISSN 0022-3034

2008), pp. 306-314, ISSN 1748-2968

39765-39771, ISSN 0021-9258

9258

frontotemporal dementia: a disorder of autophagy. *Human Molecular Genetics*, Vol.

amyotrophic lateral sclerosis. *Nature Genetics*, Vol. 40, No. 5, (May 2008), pp. 572-

neurotoxicity through RhoGEF domain by interacting with SOD1 mutants. *Journal of Biological Chemistry*, Vol. 279, No. 18, (April 2004), pp. 19247-19256, ISSN 0021-

lateral sclerosis brain tissue. *Neuroreport*, Vol. 8, No. 6, (April 1997), pp. 1337-1340,

reveal a negative role for human MOB2 in the regulation of human NDR kinases. *Molecular and Cellular Biology*, Vol. 30, No. 18, (September 2010), pp. 4507-4520, ISSN

familial amyotrophic lateral sclerosis. *Science*, Vol. 323, No. 5918, (February 2009),

genome-wide association study. *Lancet Neurology*, Vol. 9, No. 10, (October 2010), pp.

keratinocytes. *Journal of Biological Chemistry*, Vol. 276, No. 43, (October 2001), pp.

emerging roles in RNA processing and neurodegeneration. *Human Molecular* 

humans and protects motoneuron against ischemic death. *Nature Genetics*, Vol. 34,

in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the - 2578AA genotype. *Journal of Medical Genetics*, Vol. 46, No. 12, (December 2009), pp.

associated with sporadic ALS. *Amyotrophic Lateral Sclerosis*, Vol. 9, No. 5, (October

development and disease. *Journal of Neurobiology*, Vol. 58, No. 1, (January 2004), pp.


Hergovich A. (2011). MOB control: reviewing a conserved family of kinase regulators. *Cellular Signaling*, Vol. 23, No.9, (September 2011), pp.1433-1440, ISSN 0898-6568 Hervas-Stubss S., et al. (2011). Direct effects of type I interferons on cells of the immune

Hewitt C., et al. (2010). Novel FUS/TLS mutations and pathology in familial and sporadic

Hirano M., et al. (2010). Senataxin mutations in amyotrophic lateral sclerosis. *Amyotrophic Lateral Sclerosis*, Vol. 12, No. 3, (May 2011), pp. 223-227, ISSN 1748-2968 Horner RD., et al. (2003). Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. *Neurology*, Vol. 61, No. 6, (September 2003), pp. 742-749, ISSN 0028-3878 Hosler BA., et al. (2000). Linkage of familial amyotrophic lateral sclerosis with

*Association*, Vol. 284, No. 13, (October 2000), pp. 1664-1669, ISSN 0098-7484 Huang C., et al. (2011). FUS transgenic rats develop the phenotypes of amyotrophic lateral

Huang EJ., et al. (2010). Extensive FUS-immunoreactive pathology in juvenile amyotrophic

Hutton M., et al. (1998). Association of missense and 5'-splice-site mutations in tau with the

Iida A., et al. (2010). Large-scale screening of TARDBP mutation in amyotrophic lateral

Iida A., et al. (2011). Optineurin mutations in Japanese amyotrophic lateral sclerosis. *Journal of Neurology, Neurosurgery and Psychiatry*, (January 2011), ISSN 0022-3050 Iida A., et al. (2011). Replication analysis of SNPs on 9p21.2 and 19p13.11 with amyotrophic

Ilieva H, Polymenidou M & Cleveland DW. (2009). Non-cell autonomous toxicity in

Imbert G., et al. (1996). Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with

Ito D., et al. (201). Nuclear transport impairment of amyotrophic lateral sclerosis-linked

Jackson M., et al. (1996). Analysis of chromosome 5q13 genes in amyotrophic lateral

Johnson JO., et al. (2010). Exome sequencing reveals VCP mutations as a cause of familial ALS. *Neuron*, Vol. 68, No. 5, (December 2010), pp. 857-864, ISSN 0896-6273

mutations in FUS/TLS. *Annals of Neurology*, 2010, Ahead of print

1078-0432

455-461, ISSN 0003-9942

ISSN 0028-0836

pp. 757.e13-4, ISSN 0197-4580

(March 2011), pp. e1002011, ISSN 1553-7404

(November 2010), pp. 1069-1076, ISSN 1015-6305

sclerosis. *Neurobiology of Aging*, 2010, Ahead of print

6, (December 2009), pp. 761-772, ISSN 0021-9525

3, (November 1996), pp. 285-291, ISSN 1061-4036

39, No. 6, (June 1996), pp. 796-800, ISSN 0364-5134

system. *Clinical Cancer Research*, Vol. 17, No. 9, (May 2011), pp. 2619-2627, ISSN

amyotrophic lateral sclerosis. *Archives of Neurology*, Vol. 67, No. 4, (April 2010), pp.

frontotemporal dementia to chromosome 9q21-q22. *Journal of the American Medical* 

sclerosis and frontotemporal lobar degeneration. *PLoS Genetics*, Vol. 7, No. 3,

lateral sclerosis with basophilic inclusions. *Brain Pathology*, Vol. 20, No. 6,

inherited dementia FTDP-17. *Nature*, Vol. 393, No. 6686, (June 1998), pp. 702-705,

lateral sclerosis in East Asians. *Neurobiology of Aging*, Vol. 32, No. 4, (April 2011),

neurodegenerative disorders: ALS and beyond. *Journal of Cell Biology*, Vol. 187, No.

high sensitivity to expanded CAG/glutamine repeats. *Nature Genetics*, Vol. 14, No.

sclerosis: homozygous NAIP deletion in a sporadic case. *Annals of Neurology*, Vol.


Genetics of Amyotrophic Lateral Sclerosis 509

Mitchell RM., et al. (2009). HFE polymorphisms affect cellular glutamate regulation. *Neurobiology of Aging*, Vol. 32, No. 6, (June 2011), pp. 1114-1123, ISSN 0197-4580 Mizuno Y., et al. (2011). Peripherin partially localizes in Bunina bodies in amyotrophic

Morahan JM., et al. (2006). A gene-environment study of the paraoxonase 1 gene and

Moreira MC., et al. (2004). Senataxin, the ortholog of a yeast RNA helicase, is mutant in

Morita M., et al. (2006). A locus on chromosome 9p confers susceptibility to ALS and

Moulard B., et al. (1998). Association between centromeric deletions of the SMN gene and

Münch C., et al. (2004). Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. *Neurology*, Vol. 63, No. 4, (August 2004), pp. 724-726, ISSN 0028-3878 Münch C., et al. (2005). Heterozygous R1101K mutation of the DCTN1 gene in a family with

Murayama H., et al. (2010). Mutations of optineurin in amyotrophic lateral sclerosis. *Nature*,

Nadal MS., et al. (2003). The CD26-related dipeptidyl aminopeptidase-like protein DPPX is a

Nandar W & Connor JR. (2011). HFE gene variants affect iron in the brain. *Journal of Nutrition*, Vol. 141, No. 4, (April 2011), pp. 729S-739S, ISSN 0022-3166 Nardelli B., et al. (2002). Regulatory effect of IFN-κ, a novel type I IFN, on cytokine

Neumann M., et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and

Nishimura AL., et al. (2004). A mutation in the vesicle-trafficking protein VAPB causes late-

Ng CJ., et al. (2001). Paraoxonase-2 is a ubiquitously expressed protein with antioxidant

Vol. 465, No. 7295, (May 2010), pp. 223-226, ISSN 0028-0836

No. 9, (November 2002), pp. 4822-4830, ISSN 0022-1767

14-18, ISSN 0022-510X

ISSN 1061-4036

ISSN 0364-5134

133, ISSN 1095-9203

1739, ISSN

0028-3878

2007), pp. 532-540, ISSN 0161-813X

5, (May 1998), pp. 640-644, ISSN 0364-5134

(February 2003), pp. 449-461, ISSN 0896-6273

2001), pp. 44444-44449, ISSN 0021-9258

lateral sclerosis. *Journal of Neurological Sciences*, Vol. 301, No. 1-2, (March 2011), pp.

pesticides in amyotrophic lateral sclerosis. *Neurotoxicology*, Vol. 28, No. 3, (May

ataxia-ocular apraxia 2. *Nature Genetics*, Vol. 36, No. 3, (March 2004), pp. 225-227,

frontotemporal dementia. *Neurology*, Vol. 66, No. 6, (March 2006), pp. 839-844, ISSN

sporadic adult-onset lower motor neuron disease. *Annals of Neurology*, Vol. 43, No.

ALS and FTD. *Annals of Neurology*, Vol. 58, No. 5, (November 2005), pp. 777-780,

critical component of neuronal A-type K+ channels. *Neuron*, Vol. 37, No. 3,

production by cells of the innate immune system. *Journal of Immunology*, Vol. 169,

amyotrophic lateral sclerosis. *Science*, Vol. 314, No. 5796, (October 2006), pp. 130-

onset spinal muscular atrophy and amyotrophic lateral sclerosis. *American Journal of Human Genetics*, Vol. 75, No. 5, (November 2004), pp. 822-831, ISSN 0002-9297 Nonis D., et al. (2008). Ataxin-2 associates with the endocytosis complex and affects EGF

receptor trafficking. *Cellular Signalling*, Vol. 20, No. 10, (October 2008), pp. 1725-

properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. *Journal of Biological Chemistry*, Vol. 276, No. 48, (November


Le Ber I., et al. (2009). Chromosome 9p-linked families with frontotemporal dementia

Lee JA., et al. (2007). ESCRT-III dysfunction causes autophagosomes accumulation and

Lee T., et al. Ataxin-2 intermediate-length polyglutamine expansions in European ALS

Lefebvre S., et al. (1997). Correlation between severity and SMN protein level in spinal

Li XG., et al. (2009). Association between DPP6 polymorphism and the risk of sporadic

Lorson CL., et al. (1998). SMN oligomerization defect correlates with spinal muscular

Liu Y., et al. (2011). Mutant HFE H63D protein is associated with prolonged endoplasmic

Luty AA., et al. (2008). Pedigree with frontotemporal lobar degeneration – motor neuron

Mackness MI, Arrol S & Durrington PN. (1991). Paraoxonase prevents accumulation of

McLean J., et al. (2010). Distinct biochemical signatures characterize peripherin isoform

*of Human Genetics*, Vol. 67, No. 1, (July 2000), pp. 37-46, ISSN 0002-9297 Millecamps S., et al. (2010). SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial

Millecamps S., et al. (2011). Screening of OPTN in French familial amyotrophic lateral

Mitchell J., et al. (2010). Familial amytrophic lateral sclerosis is associated with a mutation in

*Genetics*, Vol. 47, No. 8, (August 2010), pp. 554-560, ISSN 0022-2593

107, No. 16, (April 2010), pp. 7556-7561, ISSN 0027-8424

No. 24, (December 2009), pp. 2989-2992, ISSN 0366-6999

Vol. 286, No. 15, (April 2011), pp. 13161-13170, ISSN 0021-9258

68, No. 5, (November 2010), pp. 639-649, ISSN 0364-5134

pp. 151-154, ISSN 0014-5793

1558-1497

1669-1676, ISSN 0028-3878

1567, ISSN 0960-9822

0964-6906

1061-4036

4036

associated with motor neuron disease. *Neurology*, Vol. 72, No. 19, (May 2009), pp.

neurodegeneration. *Current Biology*, Vol. 17, No. 18, (September 2007), pp. 1561-

patients. *Human Molecular Genetics*, Vol. 20, No. 9, (May 2011), pp. 1697-1700, ISSN

muscular atrophy. *Nature Genetics*, Vol. 16, No. 3, (July 1997), pp. 265-269, ISSN

amyotrophic lateral sclerosis in Chinese patients. *Chinese Medical Journal*, Vol. 122,

atrophy severity. *Nature Genetics*, Vol. 19, No. 1, (May 1998), pp. 63-66, ISSN 1061-

reticulum stress and increased neuronal vulnerability. *Journal of Biological Chemistry*,

disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9. *BMC Neurology*, Vol. 8, (August 2008), pp. 32, ISSN 1471-2377 Luty AA., et al. (2010). Sigma nonopioid intracellular receptor 1 mutations cause

frontotemporal lobar degeneration-motor neuron disease. *Annals of Neurology*, Vol.

lipoperoxides in low-density lipoprotein. *FEBS Letters*, Vol. 286, No. 1-2, (July 1991),

expression in both traumatic neuronal injury and motor neuron disease. *Journal of Neurochemistry*, Vol. 114, No. 4, (August 2010), pp. 1177-1192, ISSN 0022-3042 Mersiyanova IV., et al. (2000). A new variant of Charchot-Marie-Tooth disease type 2 is

probably the result of a mutation in the neurofilaments-light gene. *American Journal* 

amyotrophic lateral sclerosis: genotype-phenotype correlations. *Journal of Medical* 

sclerosis. *Neurobiology of Aging*, Vol. 32, No. 3, (March 2011), pp. 557.e11-3, ISSN

D-amino acid oxidase. *Proceedings of the National Academy of Sciences of the USA*, Vol.


Genetics of Amyotrophic Lateral Sclerosis 511

Ralser M., et al. (2004). An integrative approach to gain insights into the cellular function of

Reaume AG., et al. (1996). Motor neurons in Cu/Zn superoxide dismutase-deficient mice

Renton AE et al. (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. *Neuron*, September 2011, Ahead of print Restagno G., et al. (2007). HFE H63D polymorphism is increate in patients with amyotrophic

Rezaie T., et al. (2002). Adult-onset primary open-angle glaucoma caused by mutations in

Ricci C., et al. (2010). Lack of association of PON polymorphisms with sporadic ALS in an

Ringholz GM., et al. (2005). Prevalence and patterns of cognitive impairment in sporadic ALS. *Neurology*, Vol. 65, No. 4, (August 2005), pp. 586-590, ISSN 0028-3878 Robertson J., et al. (2003). A neurotoxic peripherin splice variant in a mouse model of ALS. *Journal of Cell Biology*, Vol. 160, No. 6, (March 2003), pp. 939-949, ISSN 0021-9525 Rollinson S., et al. (2011). Frontotemporal lobar degeneration genome wide association

*Genetics*, Vol. 13, No. 1, (May 1996), pp. 43-47, ISSN 1061-4036

Vol. 78, No. 3, (March 2007), pp. 327, ISSN 0022-3050

203-214, ISSN 0022-2836

9203

ISSN 1558-1497

789-790, ISSN 0028-3878

59-62, ISSN 0028-0836

0028-0836

1474-4422

human ataxin-2. *Journal of Molecular Biology*, Vol. 346, No. 1, (February 2005), pp.

develop normally but exhibit enhanced cell death after axonal injury. *Nature* 

lateral sclerosis of Italian origin. *Journal of Neurology, Neurosurgery and Psychiatry*,

optineurin. *Science*, Vol. 295, No. 5557, (February 2002), pp.1077-1079, ISSN 1095-

Italian population. *Neurobiology of Aging*, Vol. 32, No. 3, (March 2011), pp. 552.e7-13,

study replication confirms a risk locus shared with amyotrophic lateral sclerosis. *Neurobiology of Aging*, Vol. 32, No. 4, (April 2011), pp. 758.e1-7, ISSN 0197-4580 Rooke K., et al. (1996). Analysis of the KSP repeat of the neurofilament heavy subunit in

familial amyotrophic lateral sclerosis. *Neurology*, Vol. 46, No. 3, (March 1996), pp.

familial amyotrophic lateral sclerosis. *Nature*, Vol. 362, No. 6415, (March 1993), pp.

interaction network. *Nature*, Vol. 437, No. 7062, (October 2005), pp. 1173-1178, ISSN

(PIKfyve) regulates endosome-to-TGN retrograde transport. *Journal of Cell Science*,

involved in Golgi organization and exocytosis. *Journal of Cell Biology*, Vol. 169, No.

mechanisms. *Lancet Neurology*, Vol. 7, No. 12, (December 2008), pp. 1127-1138, ISSN

Rosen DR., et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with

Ross OA., et al. (2011). Ataxin-2 repeat-length variation and neurodegeneration. *Human Molecular Genetics*, Vol. 20, No. 16, (August 2011), pp. 3207-3212, ISSN 0964-6906 Rual JF., et al. (2005). Towards a proteome-scale map of the human protein-protein

Rutherford AC., et al. (2006). The mammalian phosphatidylinositol 3-phosphate 5-kinase

Saeed M., et al. (2006). Paraoxonase cluster polymorphisms are associated with sporadic ALS. *Neurology*, Vol. 67, No. 5, (September 2006), pp. 771-776, ISSN 0028-3878 Sahlender DA., et al. (2005). Optineurin links myosin VI to the Golgi complex and is

Salinas S., et al. (2008). Heriditary spastic paraplegia: clinical features and pathogenic

Vol. 119, Pt. 19, (October 2006), pp. 3944-3957, ISSN 0021-9533

2, (April 2005), pp. 285-295, ISSN 0021-9525


Ng SB., et al. (2009). Targeted capture and massively parallel sequencing of 12 human exomes. *Nature*, Vol. 461, No. 7261, (September 2009), pp. 272-276, ISSN 0028-0836 Oosthuyse B., et al. (2001). Deletion of the hypoxia-response element in the vascular

Orlacchio A., et al. (2010). SPATACSIN mutations cause autosomal recessive juvenile

Orozco G, Barrett JC & Zeggini E. (2010). Synthetic associations in the context of genome-

Orrell RW., et al. (1997). The relationship of spinal muscular atrophy to motor neuron

Otomo A., et al. (2003). ALS2, a novel guanine nucleotide exchange factor for the small

Parboosingh JS., et al. (1999). Deletions causing spinal muscular atrophy do not predispose

Parkinson N., et al. (2006). ALS phenotypes with mutations in CHMP2B (charged

Pasinelli P & Brown RH. (2006). Molecular biology of amyotrophic lateral sclerosis: insights

Paubel A., et al. (2008). Mutations of the ANG gene in French patients with amyotrophic

Pearson JP., et al. (2010). Familial frontotemporal dementia with amyotrophic lateral

Pestka S, Krause CD & Walter MR. (2004). Interferons, interferon-like cytokines, and their

Phillips T & Robberecht W. (2010). Neuroinflammation in amyotrophic lateral sclerosis: role

Puls I., et al. (2003). Mutant dynactin in motor neuron disease. *Nature Genetics*, Vol. 33, No. 4,

Puls I., et al. (2005). Distal spinal and bulbar muscular atrophy caused by dynactin mutation. *Annals of Neurlogy*, Vol. 57, No. 5, (May 2005), pp. 687-694, ISSN 0364-5134 Pulst SM., et al. (1996). Moderate expansion of a normally biallelic trinucleotide repeat in

*Genetics*, Vol. 28, No. 2, (June 2001), pp. 131-138, ISSN 1061-4036

ISSN 0006-8950

0022-510X

2010), pp. R137-R144, ISSN 0964-6906

pp. 710-712, ISSN 0003-9942

1074-1077, ISSN 0028-3878

723, ISSN 1471-003X

ISSN 0003-9942

2896

12, No. 14, (July 2003), pp. 1671-1687, ISSN 0964-6906

No. 4, (April 2011), pp. 647-655, ISSN 0340-5354

2010), pp. 253-263, ISSN 1474-4422

269-276, ISSN 1061-4036

(April 2003), pp. 455-456, ISSN 1061-4036

endothelial growth factor promoter causes motor neuron degeneration. *Nature* 

amyotrophic lateral sclerosis. *Brain*, Vol. 133, Pt. 2, (February 2010), pp. 591-598,

wide association scan signals. *Human Molecular Genetics*, Vol. 19, No. R2, (October

disease: investigation of SMN and NAIP gene deletions in sporadic and familial ALS. *Journal of Neurological Sciences*, Vol. 145, No. 1, (January 1997), pp. 55-61, ISSN

GTPase Rab5, is implicated in endosomal dynamics. *Human Molecular Genetics*, Vol.

to amyotrophic lateral sclerosis. *Archives of Neurology*, Vol. 56, No. 6, (June 1999),

multivesicular body protein 2B). *Neurology*, Vol. 67, No. 6, (September 2006), pp.

from genetics. *Nature Reviews Neuroscience*, Vol. 7, No. 9, (September 2006), pp. 710-

lateral sclerosis. *Archives of Neurology*, Vol. 65, No. 10, (October 2008), pp. 1333-1336,

sclerosis and a shared haplotype on chromosome 9p. *Journal of Neurology*, Vol. 258,

receptors. *Immunological reviews*, Vol. 202, (December 2004), pp. 8-32, ISSN 0105-

of glial activation in motor neuron disease. *Lancet Neurology*, Vol. 10, No. 3, (March

spinocerebellar ataxia type 2. *Nature Genetics*, Vol. 14, No. 3, (November 1996), pp.


Genetics of Amyotrophic Lateral Sclerosis 513

Subramanian V, Crabtree B & Acharya KR. (2007). Human angiogenin is a neuroprotective

Sugihara K., et al. (2011). Screening for OPTN mutations in amyotrophic lateral sclerosis in a

Sun Z., et al. (2011). Molecular determinants and genetic modifiers of aggregation and

Sutedja NA., et al. (2007). The association between H63D mutations in HFE and

Swarup V., et al. (2011). Pathological hallmarks of amyotrophic lateral

Takeda S., et al. (2000). Kinesin superfamily protein 3 (KIF3) motor transports fodrin-

Terry PD., et al. (2004). VEGF promoter haplotype and amyotrophic lateral sclerosis (ALS).

Teuling E., et al. (2007). Motor neuron disease-associated mutant vesicle-associated

Ticozzi N., et al. (2009). Mutational analysis of TARDBP in neurodegenerative disease.

Ticozzi N., et al. (2011). Mutational analysis reveals the FUS homolog TAF15 as a candidate

Tomkins J., et al. (2000). Screening of AP endonuclease as a candidate gene for amyotrophic

Topp JD., et al. (2004). Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor. *Journal* 

Troy CM., et al. (1990). Regulation of peripherin and neurofilaments expression in

Tudor EL., et al. (2010). Amyotrophic lateral sclerosis mutant vesicle-associated membrane

*Genetics*, Vol. 17, No. 1, (January 2008), pp. 130-149, ISSN 0964-6906

pp. 1923.e9-1923.e10, ISSN 1558-1497

2011), pp. e1000614, ISSN 1545-7885

7063

485X

9258

0959-4965

pp. 232-238, ISSN 0006-8993

No. 1, (January 2007), pp. 63-67, ISSN 0003-9942

TDP-43 genomic fragments. *Brain*, 2011, Ahead of print.

27, No. 36, (September 2007), pp. 9801-9815, ISSN 0270-6474

No. 6, (March 2000), pp. 1255-1265, ISSN 0021-9525

*Neurobiology of Aging*, 2009, Ahead of print.

factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. *Human Molecular* 

mainly Caucasian population. *Neurobioloy of Aging*, Vol. 32, No. 10, (October 2011),

toxicity for the ALS disease proten FUS/TLS. *PLoS Biology*, Vol. 9, No. 4, (April

amyotrophic lateral sclerosis in a Dutch population. *Archives of Neurology*, Vol. 64,

sclerosis/frontotemporal lobar degeneration in transgenic mice produced with

associating vesicles important for neurite building. *Journal of Cell Biology*, Vol. 148,

*Journal of Neurogenetics*, Vol. 18, No. 2, (April-June 2004), pp. 429-434, ISSN 0167-

membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmatic reticulum-derived tubular aggregates. *Journal of Neuroscience*, Vol.

gene for familial amyotrophic lateral sclerosis. *American Journal of Medical Genetics B: Neuropsychiatric Genetics*, Vol. 156B, No. 3, (April 2011), pp. 285-290, ISSN 1552-

lateral sclerosis (ALS). *Neuroreport*, Vol.11, No. 8 (June 2000), pp. 1695-1697, ISSN

*of Biological Chemistry*, Vol. 279, No. 23, (June 2004), pp. 24612-24623, ISSN 0021-

regenerating rat motor neurons. *Brain Research*, Vol. 529, No. 1-2, (October 1990),

protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. *Neuroscience*, Vol. 167, No. 3, (May 2010), pp. 774-785, ISSN 0306-4522


Sanpei K., et al. (1996). Identification of the spinocerebellar ataxia type 2 gene using a direct

Sapp PC., et al. (2003). Identification of two novel loci for dominantly inherited familial

Schmitt-John T., et al. (2005). Mutation of Vps54 causes motor neuron disease and defective

Schymick JC., et al. (2007). Genome-wide genotyping in amyotrophic lateral sclerosis and

Sebastià J., et al. (2009). Angiogenin protects motoneurons against hypoxic injury. *Cell Death and Differentiation*, Vol. 16, No. 9, (September 2009), pp. 1238-1247, ISSN 1350-9047 Shaikh AY & Martin LJ. (2002). DNA base-excision repair enzyme apurinic/apyrimidinic

Shatunov A., et al. (2010). Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the

Shin JS., et al. (2008). NEFL Pro22Arg mutation in Charcot-Marie-Tooth disease type 1. *Journal of Human Genetics*, Vol. 53, No. 10, (2008), pp. 936-940, ISSN 1434-5161 Siddique T., et al. (1998). X-linked dominant locus for late-onset familial amyotrophic lateral

Skibinski G., et al. (2005). Mutations in the endosomal ESCRTIII-complex subunit CHMP2B

Skourti-Stathaki K, Proudfoot NJ & Gromak N. (2011). Human senataxin resolves

Skvortsova V., et al. (2004). Analysis of heavy neurofilament subunit gene polymorphism in

*Human Genetics*, Vol. 12, No. 3, (March 2004), pp. 241-244, ISSN 1018-4813 Slowik A., et al. (2006). Paraoxonase gene polymorphisms and sporadic ALS. *Neurology*, Vol.

Sreedharan J., et al. (2008). TDP-43 mutations in familial and sporadic amytrophic lateral sclerosis. *Science*, Vol. 319, No. 5870, (March 2008), pp. 1668-1672, ISSN 1095-9203 Stevanin G., et al. (2007). Mutations in SPG11, encoding spatacsin, are a major cause of

Storkebaum E., et al. (2005). Treatment of motoneuron degeneration by

*Neuroscience*, Vol. 8, No. 1, (January 2005), pp. 85-92, ISSN 1097-6256

67, No. 5, (September 2006), pp. 766-770, ISSN 0028-3878

2007), pp. 366-372, ISSN 1061-4036

sclerosis. *American Journal of Human Genetics*, Vol. 63, Suppl. A308.

*Neurology*, Vol. 6, No. 4, (April 2007), pp. 322-328, ISSN 1474-4422

Vol. 9, No. 10, (October 2010), pp. 986-994, ISSN 1474-4422

Vol. 14, No. 3, (November 1996), pp. 277-284, ISSN 1061-4036

(August 2003), pp. 397-403, ISSN 0002-9297

2, No. 1, (2002), pp. 47-60, ISSN 1535-1084

808, ISSN 1061-4036

1097-2765

2005), pp. 1213-1215, ISSN 1061-4036

identification of repeat expansion and cloning technique, DIRECT. *Nature Genetics*,

amyotrophic lateral sclerosis. *American Journal of Human Genetics*, Vol. 73, No. 2,

spermiogenesis in the wobbler mouse. *Nature Genetics*, Vol. 37, No. 11, (November

neurologically normal controls: first stage analysis and public release of data. *Lancet* 

endonuclease/redox factor-1 is increased and competent in the brain and spinal cord of individuals with amyotrophic lateral sclerosis. *Neuromolecular Medicine*, Vol.

UK and seven other countries: a genome-wide association study. *Lancet Neurology*,

in frontotemporal dementia. *Nature Genetics*, Vol. 37, No. 8, (August 2005), pp. 806-

RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2 dependent termination. *Molecular Cell*, Vol. 42, No. 6, (June 2011), pp. 794-805, ISSN

Russian patients with sporadic motor neuron disease (MND). *European Journal of* 

spastic paraplegia with thin corpus callosum. *Nature Genetics*, Vol. 39, No. 3, (March

intracerebroventricular delivery of VEGF in a rat model of ALS. *Nature* 


Genetics of Amyotrophic Lateral Sclerosis 515

Vantaggiato C., et al. (2011). Senataaxin modulates neurite growth through fibroblast

Varoqueaux F., et al. (2002). Total arrest of spontaneous and evoked synaptic transmission

Varoqueaux F., et al. (2005). Aberrant morphology and residual transmitter release at the

Veldink JH., et al. (2001). Homozygous deletion of the survival motor neuron 2 gene is a

Veldink JH., et al. (2005). SMN genotypes producing less SMN protein increase

Vilariño-Güell C., et al. (2009). Characterization of DCTN1 genetic variability in

Wang XS., et al. (2004). Increased incidence of the Hfe mutation in amyotrophic lateral

Wang Y., et al. (2007). Vascular endothelial growth factor overexpression delays

Watts GD., et al. (2004). Inclusion body myopathy associated with Paget disease of bone and

Weihl CC., et al. (2008). TDP-43 accumulation in inclusion body myopathy muscle suggests

Williamson TL., et al. (1998). Absence of neurofilaments reduce the selective vulnerability of

Wu D., et al. (2007). Angiongenin loss-of-function mutations in amyotrophic lateral sclerosis. *Annals of Neurology*, Vol. 62, No. 6, (December 2007), pp. 609-617, ISSN 0364-5134 Xiao S., et al. (2008). An aggregate-inducing peripherin isoform generated through intron

*Genetics*, Vol. 36, No. 4, (April 2004), pp. 377-381, ISSN 1061-4036

No. 13, (June 2002), pp. 9037-9042, ISSN 0027-8424

Vol. 25, No. 14, (July 2005), pp. 5973-5984, ISSN 0270-7306

227, No. 1 (December 2004), pp. 27-33, ISSN 0022-510X

(March 2008), pp. 293-301, ISSN 1359-4184

0006-8950

752, ISSN 0028-3878

1189, ISSN 0022-3050

ISSN 0028-3878

0028-3878

2005), pp. 820-825, ISSN 0028-3878

growth factor 8 signalling. *Brain*, Vol. 134, Pt. 6, (June 2011), pp. 1808-1828, ISSN

but normal synaptogenesis in the absence of Munc13-mediated vesicle priming. *Proceedings of the National Academy of Sciences of the United States of America*, Vol. 99,

Munc13-deficient mouse neuromuscular synapse. *Molecular and Cellular Biology*,

prognostic factor in sporadic ALS. *Neurology*, Vol. 56, No. 6, (March 2001), pp. 749-

susceptibility to and severity of sporadic ALS. *Neurology*, Vol. 65, No. 6, (September

neurodegeneration. *Neurology*, Vol. 72, No. 23, (June 2009), pp. 2024-2028, ISSN

sclerosis and related cellular consequences. *Journal of the Neurological Sciences*, Vol.

neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. *Journal of Neuroscience*, Vol. 27, No. 2, (January 2007), pp. 304-307, ISSN 0270-6474 Wang J, Campbell IL & Zhang H. (2007). Systemic interferon-alpha regulates interferon-

stimulated genes in the central nervous system. *Molecular Psychiatry*, Vol. 13, No. 3,

frontotemporal dementia is caused by mutant valosin-containing protein. *Nature* 

a common pathogenic mechanism with frontotemporal dementia. *Journal of Neurology, Neurosurgery and Psychiatry*, Vol. 79, No. 10, (October 2008), pp. 1186-

motor neurons and slows disease caused by a familial amyotrophic lateral sclerosislinked superoxide dismutase 1 mutant. *Proceedings of the National Academy of Sciences of the USA*, Vol. 95, No. 16, (August 1998), pp. 9631-9636, ISSN 0027-8424 Wills AM., et al. (2009). A large-scale international meta-analysis of paraoxonase gene

polymorphisms in sporadic ALS. *Neurology*, Vol. 73, No. 1, (July 2009), pp. 16-24,

retention is upregulated in amyotrophic lateral sclerosis and associated with


Valdmanis PN., et al. (2007). Three families with amyotrophic lateral sclerosis and

Valdmanis PN & Rouleau GA. (2008). Genetics of familial amyotrophic lateral sclerosis. *Neurology*, Vol. 70, No. 2, (January 2008), pp. 144-152, ISSN 0028-3878 Van Blitterswijk M., et al. (2011). Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients. *Neurobiology of Aging*, Ahead of print, ISSN 0197-4580 Vance C., et al. (2006). Familial amyotrophic lateral sclerosis with frontotemporal dementia

Vance C., et al. (2009). Mutations in FUS, an RNA processing protein, cause familial

Van Damme P., et al. (2011). Expanded ATXN2 CAG repeat size in ALS identifies genetic

Van Deerlin VM., et al. (2008). TARDBP mutations in amyotrophic lateral sclerosis with

Van Deerlin VM., et al. (2010) Common variants at 7p21 are associated with frontotemporal

Van Es MA., et al. (2007). ITPR2 as a susceptibility gene in sporadic amyotrophic lateral

Van Es MA., et al. (2008). Genetic variation in DPP6 is associated with susceptibility to

Van Es MA., et al. (2009). A case of ALS-FTD in a large FALS pedigree with a K17I ANG mutation. *Neurology*, Vol. 72, No. 3, (January 2009), pp. 287-288, ISSN 0028-3878 Van Es MA., et al. (2009). Analysis of FGGY as a risk factor for sporadic amyotrophic lateral

Van Es MA., et al. (2009). Genome-wide association study identifies 19p13.11 (UNC13A) and

Van Vught PW., et al. (2005). Lack of association between VEGF polymorphisms and ALS in

*Genetics*, Vol. 41, No. 10 (October 2009), pp. 1083-1087, ISSN 1061-4036 Van Es MA., et al. (2011). Angiogenin variants in Parkinson's disease and amyotrophic

lateral sclerosis. *Annals of Neurology*, 2011:Ahead of print

Vol. 7, No. 5, (May 2008), pp. 409-416, ISSN 1474-4422

*Neurology*, Vol. 64, No. 2, (February 2007), pp. 240-245, ISSN 0003-9942 Valdmanis PN., et al. (2008). Association of paraoxonase gene cluster polymorphisms with

514-520, ISSN 0028-3878

pp. 868-876, ISSN 0006-8950

1208-1211, ISSN 1095-9203

2010), pp. 234-239, ISSN 1061-4036

(October 2007), pp. 869-877, ISSN 1474-4422

2072, ISSN 0028-3878

31, ISSN 1061-4036

ISSN 0028-3878

pp 441-447, ISSN 1748-2968

frontotemporal dementia with evidence of linkage to chromosome 9p. *Archives of* 

ALS in France, Quebec, and Sweden. *Neurology*, Vol. 71, No. 7, (August 2008), pp.

is linked to a locus on chromosome 9p13.2-21.3. *Brain*, Vol. 129, No. 4, (April 2006),

amyotrophic lateral sclerosis type 6. *Science*, Vol. 323, No. 5918, (February 2009), pp.

overlap between ALS and SCA2. *Neurology*, Vol. 76, No. 24, (June 2011), pp. 2066-

TDP-43 neuropathology: a genetic and histopathological analysis. *Lancet Neurology*,

lobar degeneration with TDP-43 inclusions. *Nature Genetics*, Vol. 42, No. 3, (March

sclerosis: a genome-wide association study. *Lancet Neurology*, Vol. 6, No. 10,

amyotrophic lateral sclerosis. *Nature Genetics*, Vol. 40, No. 1, (January 2008), pp. 29-

sclerosis. *Amyotrophic Lateral Sclerosis*, Vol. 10, No. 5-6, (October-December 2009),

9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. *Nature* 

a Dutch population. *Neurology*, Vol. 65, No. 10, (November 2005), pp. 1643-1645,


**22** 

*United Kingdom* 

**Genetics of Familial** 

Emily F. Goodall, Joanna J. Bury,

**Amyotrophic Lateral Sclerosis** 

Johnathan Cooper-Knock, Pamela J. Shaw and Janine Kirby

*Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield,* 

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder caused by the selective loss of motor neurones from the cortex, brainstem and spinal cord. For the patient, this results in a progressive loss of muscle function characterised by muscle weakness, atrophy and spasticity that develops into paralysis. Onset is typically in mid-life around ages 50-60 years, however there are juvenile forms with much earlier symptom onset (below 25 years). Disease duration is heterogeneous; however the majority of patients will only survive 2-3 years following initial symptom onset, with death generally resulting

A recent meta-analysis of population based studies revealed that 5% of ALS cases are familial (FALS) and the remaining 95% are sporadic (SALS) with no reported family history (Byrne et al 2011). There is a broad spectrum of inheritance for FALS ranging from fully penetrant, dominantly inherited Mendelian forms to recessive disease with weak penetrance affecting only a few family members (Simpson & Al-Chalabi 2006). The majority of familial cases are clinically and pathologically indistinguishable from sporadic cases, leading to the hypothesis that they share common pathogenic mechanisms. In addition, mutations in several of the FALS genes have also been identified in apparently sporadic disease, suggesting some degree

In ALS, cognitive impairment has been reported in up to 51% of cases, with frontotemporal dementia (FTD) present in up to 15% (Gordon et al 2011; Lillo et al 2011; Ringholz et al 2005). In approximately a third of cases, there is a family history of ALS or FTD or both in the family, and genes initially associated with either ALS or FTD are now being found to be associated with both disease phenotypes. This genetic link, in addition to extensive neuropathological evidence (Mackenzie et al 2010) has led to the widely accepted view that ALS and FTD form

The inheritance of FALS in many families is atypical with one proband and one or two first/second degree relatives who also have the disease (Valdmanis & Rouleau 2008). The first big breakthrough in the genetics of FALS came in 1993 with the discovery of

of genetic overlap (Alexander et al 2002; Chio et al 2010; Kabashi et al 2008).

part of a spectrum of the same neurodegenerative disease process (Geser et al 2010).

**1. Introduction** 

from respiratory muscle failure (Worms 2001).

**2. Overview of genetics of ALS** 

disease pathology. *Journal of Neuroscience*, Vol. 28, No. 8, (February 2008), pp. 1833- 1840, ISSN 0270-6474

